Published in J Rheumatol on January 01, 2000
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis (2004) 1.07
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Antiphospholipid syndrome infectious origin. J Clin Immunol (2004) 1.00
Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis. Rheumatol Int (2003) 0.81
Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int (2016) 0.79
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]. Med Clin (Barc) (1994) 2.03
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
[50 years of LE cells: is it time for their retirement?]. Med Clin (Barc) (1998) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus (2008) 2.00
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) (2001) 1.97
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) (2004) 1.68
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med (1994) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
The clavicle hook plate for Neer type II lateral clavicle fractures. J Orthop Trauma (2009) 1.55
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis (1998) 1.55
Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis (2004) 1.54
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus (1997) 1.52
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod (1993) 1.51
[Primary Sjögren's syndrome and lymphatic proliferation]. Med Clin (Barc) (2000) 1.47
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol (1999) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Transcatheter aortic valve replacement (TAVR) in patients with systemic autoimmune diseases. Lupus (2013) 1.41
[Intolerance to hydroxychloroquine marketed in Spain (Dolquine) in patients with autoimmune conditions]. Rev Clin Esp (2004) 1.40
[Functional abnormality of the diaphragm in the "shrinking lung" in systemic lupus erythematosus]. Rev Clin Esp (1993) 1.40
[Libman-Sacks endocarditis and anticardiolipin antibodies]. Med Clin (Barc) (1989) 1.39
[Clinical manifestations and immunology associated with chronic infection with hepatitis C virus]. Rev Clin Esp (2002) 1.39
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]. Med Clin (Barc) (1997) 1.39
A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. J Immunol Methods (1995) 1.35
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
The lung in the antiphospholipid syndrome. Ann Rheum Dis (2002) 1.33
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol (1991) 1.25
Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) (2004) 1.25
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis (2003) 1.22
Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) (1997) 1.22
Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) (2001) 1.17
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis (2004) 1.15
Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol (1999) 1.15
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis (1990) 1.14
Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus (2003) 1.13
Antiphospholipid antibodies and infections. Ann Rheum Dis (2003) 1.12
Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis (1991) 1.12
Systemic lupus erythematosus evolving into systemic vasculitis: a report of five cases. Br J Rheumatol (1993) 1.11
Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus (2003) 1.10
Incidence of fragile X in 5,000 consecutive newborn males. Genet Test (2003) 1.09
Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) (2001) 1.08
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis (2004) 1.07
Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis (2006) 1.07
Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM (2001) 1.06
Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis (1992) 1.06
Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus (2006) 1.05
The pulmonary-renal syndrome: a poorly understood clinicopathologic condition. Lupus (1999) 1.05